Vericel Corp risk profile

28 Normal where most of the sector sits

Measured 21 October 2026 from VCEL's filed statements. Recomputed nightly.

28 (Normal), driven by Competitive position at 50, over 6 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation40ElevatedStableOne-year price volatility — 40.3%
Operating pressure20NormalStableCosts outgrowing revenue — -2.5 percentage points
Cash conversion25NormalEasingCapital spending against operating cash — 0.52x
Leverage and coverage0ContainedEasingNet debt to EBITDA — -0.16x
Competitive position50ElevatedStableOperating-margin gap against peers — +0.3 percentage points
Concentration15ContainedStableCustomer concentration — 169 HHI

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Vericel Corp